Tevogen Inc. (TVGNW) stock

TVGNWNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as TVGN

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30

$0.09+0.01 (+18.24%)

Close on Oct 30, 2026Market cap $38.42MP/E –Yield –

Tevogen revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Tevogen has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.